Most of the 63 differentially expressed genes identified by TME-score, such as ARHGDIB, MYO1F,and CD14 have been demonstrated to facilitate tumor proliferation and regulate tumor immune microenvironment in breast (41) and pancreatic (42) cancers, respectively. Here, CD14 is linked to neoplasm.